The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004

J Neuroimmunol. 2004 Jul;152(1-2):1-4. doi: 10.1016/j.jneuroim.2004.03.014.

Authors

Ralf Gold¹, Richard M Ransohoff, Alfred Sandrock, Peter Rieckmann

Affiliation

¹ Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Department of Neurology, University of Würzburg, Germany. r.gold@med.unni-goettingen.de

PMID: 15303274
DOI: 10.1016/j.jneuroim.2004.03.014

No abstract available

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Blood-Brain Barrier / drug effects
Blood-Brain Barrier / immunology*
Encephalomyelitis, Autoimmune, Experimental / drug therapy
Humans
Multiple Sclerosis / drug therapy
Multiple Sclerosis / immunology*
Neuritis, Autoimmune, Experimental / drug therapy
Neuritis, Autoimmune, Experimental / immunology